Skip to main content
Premium Trial:

Request an Annual Quote

Like Mushrooms After a Good Long Rain

David Hamilton from VentureBeat has a post introducing Navigenics, a startup along the lines of 23andMe that apparently aims to provide genotyping to the consumer audience (the lure: "we can now determine your genetic predisposition for certain diseases," according to the company's website). According to Hamilton, early indications are that Navigenics will be using Affymetrix chips, while 23andMe has teamed up with Illumina.

 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.